chr1:236958592:> Detail (hg19)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr1:236,958,592-237,067,281 |
hg38 | chr1:236,795,292-236,903,981 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
0.007 | squamous cell carcinoma | NA | BeFree,GAD | Detail | |
0.003 | Carcinoma, Transitional Cell | NA | BeFree,GAD | Detail | |
0.003 | Cardiovascular Diseases | NA | BeFree,GAD | Detail | |
0.002 | Neoplastic Cell Transformation | NA | GAD | Detail | |
0.003 | intracranial aneurysm | NA | BeFree,GAD | Detail | |
0.002 | brain ischemia | NA | GAD | Detail | |
0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
0.002 | Uterine Cervical Neoplasm | NA | GAD | Detail | |
0.005 | Chromosome Aberrations | NA | GAD | Detail | |
<0.001 | Congenital chromosomal disease | NA | BeFree | Detail | |
0.132 | cleft lip | NA | CTD_human,GAD,LHGDN | Detail | |
0.132 | cleft palate | NA | CTD_human,GAD,LHGDN | Detail | |
0.005 | ulcerative colitis | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | colorectal carcinoma | Quantitative assessment of the association between MS gene polymorphism and colo... | BeFree | 25077679 | Detail |
0.005 | Colorectal Neoplasms | NA | GAD | Detail | |
0.006 | Coronary Arteriosclerosis | NA | BeFree,GAD | Detail | |
0.010 | Coronary heart disease | NA | BeFree,GAD,LHGDN | Detail | |
0.003 | Crohn Disease | NA | BeFree,GAD | Detail | |
0.002 | Hearing Loss, Sudden | NA | GAD | Detail | |
<0.001 | Presenile dementia | NA | BeFree | Detail | |
0.003 | Demyelinating Diseases | NA | BeFree,GAD | Detail | |
0.003 | Mental Depression | NA | BeFree,GAD | Detail | |
<0.001 | depressive disorder | NA | BeFree | Detail | |
0.080 | Diabetes Mellitus, Experimental | NA | RGD | Detail | |
0.080 | Diabetes Mellitus, Non-Insulin-Dependent | NA | RGD | Detail | |
0.009 | DNA Damage | NA | GAD | Detail | |
0.153 | Down syndrome | The case-control study revealed association of the polymorphism with increased f... | BeFree,CTD_human,GAD,LHGDN | 24965145 | Detail |
0.002 | drug allergy | NA | GAD | Detail | |
0.002 | Edema | NA | GAD | Detail | |
0.003 | epilepsy | NA | BeFree,GAD | Detail | |
<0.001 | Esophageal Neoplasms | NA | BeFree | Detail | |
0.002 | Fetal Growth Retardation | NA | GAD | Detail | |
0.005 | Folic Acid Deficiency | NA | BeFree,GAD | Detail | |
0.122 | Gastrointestinal Diseases | NA | CTD_human,GAD | Detail | |
0.006 | glioblastoma | NA | BeFree,LHGDN | Detail | |
0.002 | Glioma | NA | GAD | Detail | |
<0.001 | IgA glomerulonephritis | NA | BeFree | Detail | |
0.010 | Head and Neck Neoplasms | NA | GAD,LHGDN | Detail | |
0.003 | Sensorineural Hearing Loss (disorder) | NA | BeFree,GAD | Detail | |
0.010 | congenital heart defects | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Heart Septal Defects | NA | GAD | Detail | |
0.122 | Hematological Disease | NA | CTD_human,GAD | Detail | |
0.001 | homocystinuria | NA | BeFree | Detail | |
0.002 | Huntington disease | NA | GAD | Detail | |
0.003 | Hyperlipidemia | NA | BeFree,GAD | Detail | |
0.005 | Hypertensive disease | We investigated the expression of MTR and MTHFR in human term placenta obtained ... | BeFree,GAD | 25277375 | Detail |
0.003 | Inflammatory Bowel Diseases | NA | BeFree,GAD | Detail | |
0.002 | Kidney Diseases | NA | GAD | Detail | |
<0.001 | Kidney Failure, Chronic | NA | BeFree | Detail | |
0.003 | leukemia | The MTRR rs1801394>A66G (rs1801394) polymorphism is found to be associated with ... | BeFree,GAD | 24261678 | Detail |
0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.003 | Leukemia, Myelocytic, Acute | NA | BeFree,GAD | Detail | |
<0.001 | leukopenia | NA | BeFree | Detail | |
<0.001 | liver cirrhosis | NA | BeFree | Detail | |
0.003 | Chronic Obstructive Airway Disease | NA | BeFree,GAD | Detail | |
0.003 | Lung Neoplasms | NA | BeFree,GAD | Detail | |
0.005 | Lupus Erythematosus, Systemic | NA | BeFree,GAD,LHGDN | Detail | |
0.136 | lymphoma | NA | BeFree,CTD_human,GAD | Detail | |
0.123 | Lymphoma, Follicular | NA | BeFree,CTD_human,GAD | Detail | |
0.010 | Lymphoma, Non-Hodgkin | NA | BeFree,GAD | Detail | |
<0.001 | malaria | NA | BeFree | Detail | |
0.002 | Marijuana Abuse | NA | GAD | Detail | |
0.002 | Meningeal Neoplasms | NA | GAD | Detail | |
0.007 | meningioma | NA | GAD,LHGDN | Detail | |
0.002 | Metabolic Diseases | NA | GAD | Detail | |
0.006 | multiple myeloma | NA | BeFree,GAD | Detail | |
0.001 | multiple sclerosis | To investigate the impact of established MS genetic risk variants on MS phenotyp... | BeFree | 24099750 | Detail |
0.001 | multiple sclerosis | In April 2013, a symposium in Warsaw, Poland, was the first meeting entirely ded... | BeFree | 24552748 | Detail |
0.008 | myocardial infarction | NA | BeFree,GAD | Detail | |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
<0.001 | nervous system disorder | NA | BeFree | Detail | |
0.017 | Neural Tube Defects | NA | GAD,LHGDN | Detail | |
0.003 | neutropenia | NA | BeFree,GAD | Detail | |
0.003 | obesity | NA | BeFree,GAD | Detail | |
0.002 | oligospermia | NA | GAD | Detail | |
0.002 | osteosarcoma | NA | GAD | Detail | |
0.005 | Pancreatic Neoplasm | NA | GAD,LHGDN | Detail | |
0.007 | Parkinson disease | NA | GAD | Detail | |
0.120 | Peripheral neuropathy | NA | CTD_human | Detail | |
0.002 | Phenylketonurias | NA | GAD | Detail | |
0.002 | placental insufficiency | NA | GAD | Detail | |
0.003 | polycystic ovary syndrome | NA | BeFree,GAD | Detail | |
0.005 | pre-eclampsia | NA | GAD | Detail | |
0.002 | Prostatic Neoplasms | NA | GAD | Detail | |
0.002 | Psychoses, Substance-Induced | NA | GAD | Detail | |
0.153 | Down syndrome | In the present study, we determined polymorphisms of MTHFR A222V (677C > T), ... | BeFree | 15889417 | Detail |
0.003 | cervix carcinoma | Employing PCR-RFLPs and HRM analyses, we examined the prevalence of BHMT Arg239G... | BeFree | 21349258 | Detail |
0.001 | Malignant tumor of cervix | Employing PCR-RFLPs and HRM analyses, we examined the prevalence of BHMT Arg239G... | BeFree | 21349258 | Detail |
0.003 | retinoblastoma | NA | BeFree,GAD | Detail | |
<0.001 | Rheumatoid Nodule | NA | BeFree | Detail | |
0.005 | Stomach Neoplasms | NA | GAD | Detail | |
0.007 | Cerebrovascular accident | NA | BeFree,GAD | Detail | |
<0.001 | Thromboembolism | NA | BeFree | Detail | |
0.120 | Adverse reaction to drug | NA | CTD_human | Detail | |
0.006 | Vascular Diseases | NA | BeFree,GAD,LHGDN | Detail | |
0.002 | Venous Thrombosis | NA | GAD | Detail | |
0.081 | Vitamin B 12 Deficiency | NA | BeFree,RGD | Detail | |
0.002 | Vitamin B Deficiency | NA | GAD | Detail | |
0.003 | B-Cell Lymphomas | NA | BeFree,GAD | Detail | |
0.003 | diffuse large B-cell lymphoma | NA | BeFree,GAD | Detail | |
<0.001 | Lymphoma, Large-Cell, Follicular | NA | BeFree | Detail | |
0.002 | T-Cell Lymphoma | NA | GAD | Detail | |
0.016 | spina bifida | NA | BeFree,GAD,LHGDN | Detail | |
0.007 | Central Nervous System Neoplasms | NA | GAD | Detail | |
0.002 | Neoplasms, Second Primary | NA | GAD | Detail | |
<0.001 | essential hypertension | NA | BeFree | Detail | |
<0.001 | Deep Vein Thrombosis | NA | BeFree | Detail | |
<0.001 | Small cell carcinoma of lung | NA | BeFree | Detail | |
0.003 | Migraine Disorders | NA | BeFree,GAD | Detail | |
0.002 | Myocardial Ischemia | NA | GAD | Detail | |
<0.001 | Pleocytosis | NA | BeFree | Detail | |
<0.001 | Deep thrombophlebitis | NA | BeFree | Detail | |
<0.001 | esophageal carcinoma | NA | BeFree | Detail | |
<0.001 | congenital heart disease | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of brain | NA | GAD | Detail | |
<0.001 | migraine with aura | NA | BeFree | Detail | |
<0.001 | Cleft palate with cleft lip | NA | BeFree | Detail | |
0.002 | adrenoleukodystrophy | NA | GAD | Detail | |
0.002 | iron deficiency anemia | NA | GAD | Detail | |
0.122 | Malnutrition | NA | CTD_human,GAD | Detail | |
<0.001 | Prion Diseases | NA | BeFree | Detail | |
0.002 | Aortic Aneurysm, Abdominal | NA | GAD | Detail | |
0.003 | Cervical Intraepithelial Neoplasia | NA | BeFree,GAD | Detail | |
<0.001 | Lesion of brain | NA | BeFree | Detail | |
<0.001 | Fibrillation | NA | BeFree | Detail | |
<0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
0.002 | coronary stenosis | NA | GAD | Detail | |
0.011 | Malignant neoplasm of lung | NA | BeFree,GAD | Detail | |
0.005 | age related macular degeneration | NA | GAD | Detail | |
<0.001 | Chronic Periodontitis | NA | BeFree | Detail | |
0.120 | Leukoencephalopathies | NA | CTD_human | Detail | |
<0.001 | Coinfection | NA | BeFree | Detail | |
<0.001 | Malignant Childhood Neoplasm | NA | BeFree | Detail | |
<0.001 | adult meningioma | NA | BeFree | Detail | |
0.003 | Cancer of Head and Neck | NA | BeFree,GAD | Detail | |
0.480 | Methylcobalamin Deficiency, CblG Type | Human methionine synthase: cDNA cloning and identification of mutations in patie... | UNIPROT | 8968737 | Detail |
<0.001 | Squamous cell carcinoma of esophagus | NA | BeFree | Detail | |
<0.001 | Adenocarcinoma Of Esophagus | NA | BeFree | Detail | |
<0.001 | cervical squamous cell carcinoma | NA | BeFree | Detail | |
<0.001 | Transitional cell carcinoma of bladder | NA | BeFree | Detail | |
<0.001 | Primary central nervous system lymphoma | NA | BeFree | Detail | |
0.003 | cervix carcinoma | NA | BeFree,GAD | Detail | |
<0.001 | Impaired cognition | NA | BeFree | Detail | |
<0.001 | Deep vein thrombosis of lower limb | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Cervical intraepithelial neoplasia grade 2 | NA | BeFree | Detail | |
0.002 | Avitaminosis | NA | GAD | Detail | |
0.009 | Malignant neoplasm of prostate | NA | BeFree,GAD | Detail | |
<0.001 | dementia | NA | BeFree | Detail | |
0.002 | body mass | NA | GAD | Detail | |
0.002 | Retinal Neoplasms | NA | GAD | Detail | |
0.003 | Malignant neoplasm of esophagus | NA | BeFree,GAD | Detail | |
0.002 | Methotrexate poisoning | NA | GAD | Detail | |
<0.001 | Severe depression | NA | BeFree | Detail | |
0.002 | Carcinogenesis | NA | BeFree | Detail | |
0.022 | hyperhomocysteinemia | NA | BeFree,GAD,LHGDN | Detail | |
0.001 | prostate carcinoma | NA | BeFree | Detail | |
0.005 | Choroidal Neovascularization | NA | GAD | Detail | |
0.005 | breast carcinoma | Association of methylenetetrahydrofolate reductase and methionine synthase polym... | BeFree | 25217320 | Detail |
0.005 | breast carcinoma | Therefore, DNA methylation related genes, such as methylenetetrahydrofolate redu... | BeFree | 25270516 | Detail |
0.005 | breast carcinoma | Association between dietary intake of folate and MTHFR and MTR genotype with ris... | BeFree | 25366783 | Detail |
0.005 | breast carcinoma | Loss of heterogeneity (LOH) of the MIIP gene was determined using single-nucleot... | BeFree | 25873164 | Detail |
0.001 | Carcinoma of lung | NA | BeFree | Detail | |
0.002 | Chronic progressive chorea | NA | GAD | Detail | |
<0.001 | colon carcinoma | NA | BeFree | Detail | |
0.002 | Carcinoma of bladder | NA | BeFree | Detail | |
0.002 | Cardiac defects | NA | GAD | Detail | |
<0.001 | Brain Tumor, Primary | NA | BeFree | Detail | |
<0.001 | Cancer of Digestive System | NA | BeFree | Detail | |
<0.001 | adult acute lymphocytic leukemia | NA | BeFree | Detail | |
<0.001 | Multiple Sclerosis, Primary Progressive | NA | BeFree | Detail | |
0.028 | Malignant neoplasm of breast | In this case-control study, we investigated the association between MTHFR C677T ... | BeFree | 22134752 | Detail |
0.153 | Down syndrome | In conclusion, the presence of three or more polymorphic alleles for MTHFR C677T... | BeFree | 18273817 | Detail |
<0.001 | Ischemic stroke | NA | BeFree | Detail | |
0.002 | Acute coronary syndrome | NA | GAD | Detail | |
0.010 | Coronary heart disease | Compound mutants for (MTHFD-G1958A, MTHFR-C677T and MTR-A2756G) and (MTHFD-G1958... | BeFree | 23701284 | Detail |
<0.001 | neuroblastoma | The aim of this study was to investigate whether the genetic polymorphisms MTHFR... | BeFree | 24771227 | Detail |
<0.001 | Central neuroblastoma | The aim of this study was to investigate whether the genetic polymorphisms MTHFR... | BeFree | 24771227 | Detail |
0.005 | breast carcinoma | In this case-control study, we investigated the association between MTHFR C677T ... | BeFree | 22134752 | Detail |
<0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
0.004 | Adenoma of large intestine | NA | BeFree,GAD | Detail | |
<0.001 | Megaloblastic anemia due to inborn errors of metabolism | NA | BeFree | Detail | |
<0.001 | childhood leukemia | NA | BeFree | Detail | |
0.123 | Mammary Neoplasms | NA | CTD_human,LHGDN | Detail | |
0.042 | colorectal cancer | Quantitative assessment of the association between MS gene polymorphism and colo... | BeFree,GAD | 25077679 | Detail |
<0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
<0.001 | Benign Prostatic Hyperplasia | NA | BeFree | Detail | |
0.002 | Fetus affected by placental transfer of anticonvulsant | NA | GAD | Detail | |
<0.001 | Fast acetylator due to N-acetyltransferase enzyme variant | NA | BeFree | Detail | |
0.120 | orofacial cleft 1 | NA | CTD_human | Detail | |
0.120 | Neural tube defect, folate-sensitive | NA | CTD_human | Detail | |
0.010 | coronary artery disease | NA | BeFree,GAD | Detail | |
<0.001 | Cardiac Carcinoma | NA | BeFree | Detail | |
0.010 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,GAD | Detail | |
<0.001 | Leukemia, B-Cell | NA | BeFree | Detail | |
<0.001 | Urothelial Carcinoma | NA | BeFree | Detail | |
<0.001 | liver carcinoma | NA | BeFree | Detail | |
<0.001 | High grade dysplastic nodule | NA | BeFree | Detail | |
<0.001 | Ischemic Cerebrovascular Accident | NA | BeFree | Detail | |
<0.001 | Severe dementia | NA | BeFree | Detail | |
0.002 | Homocysteinemia | NA | BeFree | Detail | |
<0.001 | Opticospinal Multiple Sclerosis | NA | BeFree | Detail | |
0.002 | Hyperhomocystinemia | NA | GAD | Detail | |
0.005 | Congenital Abnormality | NA | BeFree,GAD | Detail | |
0.007 | adenocarcinoma | NA | GAD | Detail | |
0.005 | adenoma | NA | GAD,LHGDN | Detail | |
0.008 | Alzheimer's disease | NA | BeFree,GAD | Detail | |
<0.001 | anorexia nervosa | NA | BeFree | Detail | |
0.010 | rheumatoid arthritis | NA | BeFree,GAD | Detail | |
0.005 | atherosclerosis | NA | GAD | Detail | |
0.003 | autistic disorder | NA | BeFree,GAD | Detail | |
0.003 | azoospermia | NA | BeFree,GAD | Detail | |
0.003 | bipolar disorder | NA | BeFree,GAD | Detail | |
0.016 | Malignant neoplasm of urinary bladder | NA | BeFree,GAD | Detail | |
0.005 | Bladder Neoplasm | NA | GAD,LHGDN | Detail | |
0.002 | Bone neoplasms | NA | GAD | Detail | |
0.005 | Brain Neoplasms | NA | GAD | Detail | |
0.028 | Malignant neoplasm of breast | Association of methylenetetrahydrofolate reductase and methionine synthase polym... | BeFree,GAD | 25217320 | Detail |
0.028 | Malignant neoplasm of breast | Therefore, DNA methylation related genes, such as methylenetetrahydrofolate redu... | BeFree,GAD | 25270516 | Detail |
0.028 | Malignant neoplasm of breast | Association between dietary intake of folate and MTHFR and MTR genotype with ris... | BeFree,GAD | 25366783 | Detail |
0.028 | Malignant neoplasm of breast | Loss of heterogeneity (LOH) of the MIIP gene was determined using single-nucleot... | BeFree,GAD | 25873164 | Detail |
0.003 | Malignant tumor of colon | NA | BeFree,GAD | Detail | |
0.003 | Non-small cell lung carcinoma | NA | BeFree,GAD | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Quantitative assessment of the association between MS gene polymorphism and colorectal cancer risk. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The case-control study revealed association of the polymorphism with increased folate levels, and a ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We investigated the expression of MTR and MTHFR in human term placenta obtained from normal and preg... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The MTRR rs1801394>A66G (rs1801394) polymorphism is found to be associated with decreased enzyme aff... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To investigate the impact of established MS genetic risk variants on MS phenotypes, in well-characte... | DisGeNET | Detail |
In April 2013, a symposium in Warsaw, Poland, was the first meeting entirely dedicated to advances i... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In the present study, we determined polymorphisms of MTHFR A222V (677C > T), MTHFR E429A (1298A &... | DisGeNET | Detail |
Employing PCR-RFLPs and HRM analyses, we examined the prevalence of BHMT Arg239Gln (rs3733890), MTR ... | DisGeNET | Detail |
Employing PCR-RFLPs and HRM analyses, we examined the prevalence of BHMT Arg239Gln (rs3733890), MTR ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG comp... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast... | DisGeNET | Detail |
Therefore, DNA methylation related genes, such as methylenetetrahydrofolate reductase (MTHFR), methi... | DisGeNET | Detail |
Association between dietary intake of folate and MTHFR and MTR genotype with risk of breast cancer. | DisGeNET | Detail |
Loss of heterogeneity (LOH) of the MIIP gene was determined using single-nucleotide polymorphism (SN... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
In this case-control study, we investigated the association between MTHFR C677T and A1298C, TYMS 5'-... | DisGeNET | Detail |
In conclusion, the presence of three or more polymorphic alleles for MTHFR C677T, MTHFR A1298C, MTR ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Compound mutants for (MTHFD-G1958A, MTHFR-C677T and MTR-A2756G) and (MTHFD-G1958A, RFC1-G80A and MTR... | DisGeNET | Detail |
The aim of this study was to investigate whether the genetic polymorphisms MTHFR C677T and A1298C, M... | DisGeNET | Detail |
The aim of this study was to investigate whether the genetic polymorphisms MTHFR C677T and A1298C, M... | DisGeNET | Detail |
In this case-control study, we investigated the association between MTHFR C677T and A1298C, TYMS 5'-... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Quantitative assessment of the association between MS gene polymorphism and colorectal cancer risk. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast... | DisGeNET | Detail |
Therefore, DNA methylation related genes, such as methylenetetrahydrofolate reductase (MTHFR), methi... | DisGeNET | Detail |
Association between dietary intake of folate and MTHFR and MTR genotype with risk of breast cancer. | DisGeNET | Detail |
Loss of heterogeneity (LOH) of the MIIP gene was determined using single-nucleotide polymorphism (SN... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs28933097 dbSNP
- Genome
- hg19
- Position
- chr1:236,958,592-237,067,281
- Variant Type
- snv
Genome browser